Tucuvi has raised $20 million in Series A funding to accelerate adoption of its AI Care Management platform across healthcare organizations, as systems grapple with workforce shortages, rising demand, and increasing operational complexity. The round was co-led by Cathay Innovation and Kfund through its early-growth fund Leadwind, with participation from existing investors Frontline Ventures, Seaya Ventures, and Shilling.
Tucuvi will use the funding to expand go-to-market efforts across Europe and the U.S., deepen its agentic AI capabilities, and continue product development.
The company positions its platform as a system built not just to observe or document care, but to actively deliver and orchestrate care at scale. Tucuvi’s AI Care Management platform is designed to automate high-volume workflows end to end, combining autonomous patient engagement with workflow logic, escalation pathways, documentation, and integration into health system operations.
At the center of the platform is a set of AI agents, including LOLA, a Voice AI agent that conducts patient phone conversations, carries out clinical and care coordination workflows, and escalates to human teams when required. Tucuvi said its platform currently supports more than 50 workflows, spanning post-surgical follow-ups, transitions of care, chronic care management, pre-operative assessments, screenings, scheduling, and medication management.
Tucuvi is emphasizing trust, safety, and clinical governance as differentiators as healthcare organizations begin deploying more autonomous systems. The company said it is the first platform to receive European regulatory approval as a Class IIb Software as a Medical Device (SaMD) for both its Voice AI agent and its patient management platform, positioning it for broader real-world use cases where clinical risk, auditability, and oversight are central.
The company also highlighted performance metrics it says have been demonstrated across partner health systems, including up to 80% automation of nursing follow-up workflows, patient reach and engagement above 90% in high-complexity populations, and chronic care outcome improvements such as a 5.5% reduction in COPD readmissions.
Tucuvi said the platform is modular and can be adapted to local workflows, regulatory requirements, and care models, helping providers scale care management without increasing clinical workload or disrupting existing operations. With the Series A, the company plans to expand deployments and broaden the range of care workflows that can be executed through its agentic approach, moving organizations from isolated automations to more comprehensive, end-to-end care management.
KEY QUOTES:
“Healthcare is under immense pressure, and incremental tools are no longer enough. The only way to continue delivering high-quality care at scale is with AI that healthcare organizations can truly trust – AI that is safe, auditable, and built for real clinical environments. We’re proud to already serve more than 60 healthcare organizations and to be expanding rapidly to meet growing demand.”
Maria Gonzalez, Co-Founder and CEO, Tucuvi
“Tucuvi transforms protocols and guidelines into actual, reliable, and consistent AI workflows, enabling us to engage with all our patients and allow nursing teams to focus on cases that require high-value clinical judgment.”
Chief Medical Officer of a Health System
“What convinced us at Cathay Innovation is Tucuvi’s rare ability to combine clinical rigor, regulatory credibility, and real-world scalability in one platform. Their approach enables healthcare organizations to deploy autonomous AI with confidence, unlocking meaningful capacity for care teams while maintaining the highest levels of safety and quality. We believe Tucuvi is breaking new ground for how AI can be responsibly embedded into healthcare operations.”
Jacky Abitbol, Managing Partner, Cathay Innovation
